Research Analysts Issue Forecasts for RNAC FY2025 Earnings
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Cartesian Therapeutics in a report released on Monday, March 17th. Cantor Fitzgerald analyst K. Kluska forecasts that the company will post earnings of ($3.65) per share for the year. Cantor Fitzgerald has a “Hold” rating on the […]
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Cartesian Therapeutics in a report released on Monday, March 17th. Cantor Fitzgerald analyst K. Kluska forecasts that the company will post earnings of ($3.65) per share for the year. Cantor Fitzgerald has a “Hold” rating on the […]
